Drug intelligence / Profile preview

galacto-oligosaccharides + fructo-oligosaccharides

Development stage
Unknown
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Galacto-oligosaccharides + fructo-oligosaccharides is a combination of two non-digestible carbohydrates classified as prebiotics. Both components are oligosaccharide fibers that resist digestion in the upper gastrointestinal tract and reach the colon intact, where they selectively stimulate the growth and activity of beneficial gut bacteria such as Bifidobacteria and Lactobacilli[1][5][6]. This synbiotic effect can improve gut health by enhancing digestion, increasing stool frequency, supporting immune function, improving mineral absorption (such as calcium), and potentially reducing inflammation[5][6][7]. The combination is commonly used in infant formulas to mimic some functional properties of human milk oligosaccharides and may help prevent or relieve constipation, eczema (atopic dermatitis), colic in infants, hay fever (allergic rhinitis), food allergies, irritable bowel syndrome (IBS), Crohn’s disease, ulcerative colitis/pouchitis after surgery for UC, osteoporosis prevention via improved mineral absorption, and other digestive disorders[1][9]. Both GOS and FOS are also used as low-calorie sweeteners due to their mild sweetness[2].\n\nMechanistically, these compounds act primarily by serving as fermentable substrates for commensal bacteria in the colon. Their fermentation produces short-chain fatty acids that further support gut barrier integrity and modulate immune responses. They do not directly interact with human cellular targets but exert effects through modulation of microbiota composition (“microbiome therapy”)[5][6].

Other names
GOS + FOSgalactooligosaccharides + fructooligosaccharidesprebiotic oligosaccharide blend

Beyond the preview

Go deeper on galacto-oligosaccharides + fructo-oligosaccharides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on galacto-oligosaccharides + fructo-oligosaccharides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call